ArticleCell communication and signaling : CCS2026
TBK1-NQO1 negative feedback loop regulates antiviral innate immunity.
Article in Cell communication and signaling : CCS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Pituitary adenomas (PitNETs): molecular pathophysiology, targeted drug delivery strategies and clinical therapeutic outcomes.Molecular biology reports · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
TANK-binding kinase 1 (TBK1) is an essential kinase that phosphorylates transcriptional factors, which induce antiviral interferons and inflammatory cytokines against viral infection. Tight regulation of TBK1 is critical for innate immune responses and maintenance of homeostasis. Here, we report that NAD(P)H: quinone-oxidoreductase-1 (NQO1) forms a negative feedback loop with TBK1 to regulate innate antiviral immune responses. At the late time stages of virus infection, NQO1 specifically interacts with TBK1 and is phosphorylated at S82 of NQOI by TBK1. Interestingly, S82-phosphorylated NQO1 interferes with the self-association and phosphorylation of TBK1, resulting in reduced type I IFN signaling cascades. Depletion or reduced expression of NQO1 increases secretion of antiviral cytokines and resultes in less viral replication. In particular, NQO1−/− mice are more resistant to viral infection due to the enhanced secretion of antiviral cytokines. Taken together, these finding provide new insight into the molecular regulation of NQOI and TBK1 and suggest a critical role for NQOI in the homeostatic control of antiviral response and innate immune responses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.